Acadia Pharmaceuticals 对比 Collegium Pharmaceutical
可添加、更换或移除公司，最多四家。
简而言之
- Acadia Pharmaceuticals 规模更大:2025 财年营收 $1.1B，Collegium Pharmaceutical 为 $781M。
- Collegium Pharmaceutical 营收增长更快(23.6%，对方为 11.9%)。
- Collegium Pharmaceutical 每一美元销售额中留下的营业利润更多(营业利润率 23.0%，对方为 9.8%)。
- Collegium Pharmaceutical 将更多销售额转化为自由现金流(自由现金流利润率 42.0%，对方为 9.8%)。
- 投资者愿为 Collegium Pharmaceutical 每一美元的盈利支付更高价格：市盈率 18.5x，而 Acadia Pharmaceuticals 为 8.8x。
| 最近财年 | ACAD · FY25 | COLL · FY25 |
|---|---|---|
| 规模 | ||
| 市值 | $3.4B | $746M |
| 营收 | $1.1B | $781M |
| 自由现金流 | $105M | $328M |
| 净利润 | $391M | $62.9M |
| 增长 | ||
| 营收增长 | 11.9% | 23.6% |
| 5年增长率 | 19.4% | 20.3% |
| 股数变化 | 2.1% | −1.8% |
| 盈利能力 | ||
| 毛利率 | 91.7% | 59.4% |
| 营业利润率 | 9.8% | 23.0% |
| 净利率 | 36.5% | 8.1% |
| 自由现金流利润率 | 9.8% | 42.0% |
| 资本回报率 | — | 53.4% |
| 股本回报率 | 39.9% | 23.7% |
| 资产负债表 | ||
| 净债务 | — | −$149M |
| 净债务 / EBITDA | — | −0.4x |
| 股息与回购 | $0.0M | $25.1M |
| 估值与质量 | ||
| 市盈率 | 8.8x | 18.5x |
| Piotroski F 分数 | — | 6 |
FY16
ACAD $17.3M
COLL $1.7M
FY17
ACAD $125M
COLL $28.5M
FY18
ACAD $224M
COLL $280M
FY19
ACAD $339M
COLL $297M
FY20
ACAD $442M
COLL $310M
FY21
ACAD $484M
COLL $277M
FY22
ACAD $517M
COLL $464M
FY23
ACAD $726M
COLL $567M
FY24
ACAD $958M
COLL $631M
FY25
ACAD $1.1B
COLL $781M
ACAD
COLL
FY16
ACAD −1,574.1%
COLL −5,498.7%
FY17
ACAD −234.1%
COLL −265.0%
FY18
ACAD −110.6%
COLL −7.4%
FY19
ACAD −72.7%
COLL −8.0%
FY20
ACAD −64.9%
COLL 18.1%
FY21
ACAD −35.2%
COLL 6.4%
FY22
ACAD −43.2%
COLL 7.2%
FY23
ACAD −10.1%
COLL 29.5%
FY24
ACAD 24.1%
COLL 26.9%
FY25
ACAD 9.8%
COLL 23.0%
ACAD
COLL
FY16
ACAD −$210M
COLL −$75.5M
FY17
ACAD −$219M
COLL −$68.0M
FY18
ACAD −$170M
COLL $164M
FY19
ACAD −$152M
COLL $21.3M
FY20
ACAD −$144M
COLL $88.4M
FY21
ACAD −$127M
COLL $102M
FY22
ACAD −$114M
COLL $123M
FY23
ACAD $16.7M
COLL $274M
FY24
ACAD $157M
COLL $203M
FY25
ACAD $105M
COLL $328M
ACAD
COLL
FY16
ACAD —
COLL —
FY17
ACAD —
COLL —
FY18
ACAD —
COLL —
FY19
ACAD —
COLL —
FY20
ACAD —
COLL —
FY21
ACAD —
COLL 10.4%
FY22
ACAD —
COLL 16.5%
FY23
ACAD —
COLL 68.7%
FY24
ACAD —
COLL 53.0%
FY25
ACAD —
COLL 53.4%
ACAD
COLL
各公司最近一个财年的数据；各公司财年结束月份不同。在越高(或越低)明显越好的行中，突出显示最佳值。不构成投资建议。